Our Guide to the 2017 ISBD Conference

The International Society for Bipolar Disorders conference is happening this week from Thursday to Sunday. CREST.BD team members and friends from all over the world will be at the conference, and some of us are part of the scientific program (to search for a specific team member, click here). Here’s a list of where to find us during the conference:

THURSDAY

09:00 – 09:45	LIVING THE SCIENCE: A CASE-BASED ILLUSTRATION OF THE RESEARCH IN PEDIATRIC BIPOLAR DISORDER
	Eric Youngstrom, USA

14:00 – 16:00	FAMILY-FOCUSED TREATMENT OF BIPOLAR DISORDER
	David J. Miklowitz, USA

FRIDAY

14:00 – 14:30	RANDOMIZED CLINICAL TRIALS OF MITOCHONDRIAL AGENTS FOR THE TREATMENT OF BIPOLAR DEPRESSION	S-023
	M. Berk¹ ¹School of Medicine, Deakin University, Australia

SATURDAY

08:30 – 09:00	CIRCADIAN MODULATION OF REWARD: FMRI INVESTIGATION OF A COMPLEX BIPOLAR DISORDER DIATHESIS	S-050
	G. Murray¹, Jamie Byrne¹, Hughes, M., S. Rossell¹, S. Johnson², G. Malhi³ ¹Swinburne University of Technology, Melbourne, Australia ²University of California, Berkeley, USA ³University of Sydney, Australia

4:30 – 14:45	A DUAL-ROLE MODEL FOR FIGHTING BIPOLAR DISORDERS STIGMA: TRANSLATING AND MOBILIZING KNOWLEDGE AS A RESEARCHER-PATIENT	RC-20
	N. Kolida¹ ¹University of British Columbia, Faculty of Education, Vancouver, Canada

14:45 – 15:00	WHAT DOES ‘QUALITY OF LIFE’ REFER TO IN BIPOLAR DISORDER RESEARCH? A SYSTEMATIC REVIEW OF THE CONSTRUCT’S DEFINITION, USAGE, AND MEASUREMENT	RC-21
	E. Morton¹, E. Michalak², G. Murray¹ ¹Swinburne University of Technology, Department of Psychological Sciences, Hawthorn, Australia ²University of British Columbia, Department of Psychiatry, Vancouver, Canada

SUNDAY

08:30 – 09:00	OUTCOMES FOLLOWING LITHIUM VERSUS QUETIAPINE DURING ONE YEAR TREATMENT IN EARLY BIPOLAR DISORDER	S-086
	M. Berk¹ ¹School of Medicine, Deakin University and Barwon Health, University of Melbourne, Parkville, Victoria, Australia.Melbourne, Australia

11:30 – 13:30	POS18-42 – INCLUSIVITY, SUPPORT, MUTUAL RESPECT AND CO-BUILDING IN BIPOLAR RESEARCH: A CANADIAN PERSPECTIVE	42
	S. Lapsley¹ ¹University of British Columbia, Department of Psychiatry, New Westminster, Canada

09:00 – 09:30	CAN EARLY INTERVENTION IN BIPOLAR DISORDER IMPACT CLINICAL OUTCOMES AND COGNITIVE FUNCTIONING?	S-087
	L. Yatham¹ ¹University of British Columbia, University of British Columbia, Vancouver, BC, Canada

09:00 – 09:30	FAMILY INTERVENTION IN THE EARLY STAGES OF BIPOLAR DISORDER	S-093
	D. Miklowitz¹, P. Walshaw¹, A. Garrett², C. Schneck³, M.K. Singh⁴, Chang, K.D. ¹University of California, Los Angeles School of Medicine, Los Angeles, CA, USA ²University of Texas San Antonio Health Science Center, San Antonio, TX, USA ³University of Colorado Denver Health Center, Denver, CO, USA ^{4)Stanford University School of Medicine, Stanford, CA, USA}


11:30 – 13:30	POS18-58 – EFFICACY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I MANIA BY BASELINE SYMPTOM SEVERITY: A POOLED, POST HOC ANALYSIS	58
	L. Yatham¹, W. Earley², C. Cheng-Tao³, Á. Barabássy⁴ ¹University of British Columbia, Department of Psychiatry, Vancouver, Canada ²Allergan, Clinical Development, Jersey City, USA ³Allergan, Biostatistics, Jersey City, USA ⁴Gedeon Richter, Medical Division, Budapest, Hungary

11:30 – 13:30	POS19-80 – LIKE DOING THERAPY AT A PARTY: ONLINE PSYCHOSOCIAL TREATMENT FOR BIPOLAR DISORDER	80
	G. Murray¹, K. Fletcher¹, F. Foley¹, N. Thomas¹ ¹Swinburne University, Psychological Sciences, Hawthorn, Australia

13:30 – 14:00	KNOWLEDGE TRANSLATION ONLINE: WHERE SHOULD WE PUT OUR ENERGY FOR MAXIMUM IMPACT?	S-110
	E. Michalak¹, E. Gliddon², G. Murray³ ¹Department of Psychiatry, University of British Columbia, Vancouver, Canada ²IMPACT Strategic Research Centre, Deakin University, Geelong, Australia ³Swinburne University, Melbourne, Australia

14:00 – 14:30	DISCUSSION FORUM ENGAGEMENT WITHIN AN INTERNET-BASED PROGRAM FOR BIPOLAR DISORDER: IMPACTS ON SOCIAL SUPPORT, STIGMA, QUALITY OF LIFE AND MOOD SEVERITY	S-111
	E. Gliddon¹, L. Berk¹, S. Lauder², V. Cosgrove³, D. Grimm⁴, S. Dodd¹, T. Suppes⁴, M. Berk¹ ¹IMPACT Strategic Research Centre, Deakin University, Geelong, Australia ²Federation University, Ballarat, Australia ³Stanford University School of Medicine, Stanford, USA ⁴VA Palo Alto Healthcare System, Palo Alto, USA